1044-P: The Impact of Basal Insulin Type, Prandial Dosing Plan, and Baseline Postprandial Glucose (PPG) on Glycemic Control after Treatment with Ultra-Rapid Lispro (URLi) or Humalog in Type 1 Diabetes: Planned Subgroup Analyses from PRONTO-T1D
Sign Up to like & getrecommendations! Published in 2020 at "Diabetes"
DOI: 10.2337/db20-1044-p
Abstract: URLi is a novel prandial insulin lispro formulation developed to more closely match physiological insulin secretion and improve PPG control. In PRONTO-T1D, a phase 3, 26-week, treat-to-target study comparing URLi to Humalog in patients with… read more here.
Keywords: insulin; control; treatment; pronto t1d ... See more keywords
232-OR: Long-Term Safety and Efficacy of Ultra-Rapid Lispro (URLi) in PRONTO-T1D
Sign Up to like & getrecommendations! Published in 2020 at "Diabetes"
DOI: 10.2337/db20-232-or
Abstract: PRONTO T1D was a phase 3 study evaluating ultra rapid lispro (URLi) in adults with type 1 diabetes (T1D) for 52 weeks. Subjects were randomized to double-blind mealtime URLi, Humalog, or open-label postmeal URLi with… read more here.
Keywords: ultra rapid; long term; pronto t1d; lispro urli ... See more keywords
Efficacy and Safety of Ultra-Rapid Lispro Versus Lispro in Patients with Type 1 and 2 Diabetes: Indian Subpopulation Analyses of the PRONTO-T1D and PRONTO-T2D Trials
Sign Up to like & getrecommendations! Published in 2022 at "Indian Journal of Endocrinology and Metabolism"
DOI: 10.4103/ijem.ijem_459_21
Abstract: 186 Sir, Although advances have been made in the treatment of both type 1 and 2 diabetes, many patients still do not achieve sufficient glycaemic control.[1] The reasons behind this are multifactorial, but post‐prandial hyperglycaemia… read more here.
Keywords: patients type; rapid lispro; t1d pronto; type diabetes ... See more keywords